FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to pharmacology, and refers to water-soluble humic acids isolated from the upper pine-sphagnum-cotton grass peat type for the correction of disorders in the immune system in pathological conditions associated with the deficiency of the Th1-dependent immune response.
EFFECT: invention provides an expansion of the arsenal of targeted nontoxic immunomodulating agents of plant origin by selectively increasing the production of pro-inflammatory cytokines of interleukin-2, interleukin-12, tumor necrosis factor-alpha by macrophages and interferon-gamma lymphocytes, accompanied by a lack of influence on the production of interleukin-4 and interleukin-10.
1 cl, 2 dwg, 12 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
| HUMIC SUBSTANCE HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2716504C1 |
| PRODUCT OF HUMIC NATURE WITH ANTI-ALLERGIC ACTIVITY | 2020 |
|
RU2750098C1 |
| IMMUNOMODULATING HUMIC AGENT | 2020 |
|
RU2756353C1 |
| AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
| PREPARATION, INCREASING PRODUCTION OF NITROGEN OXIDE BY MACROPHAGES IN VITRO, BASED ON HUMIC ACIDS OF PEAT OF TOMSK REGION BOGS AND METHOD FOR OBTAINING THEREOF | 2015 |
|
RU2610446C2 |
| MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
| IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
| MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
| IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
